MeSH tree: N05.715.360.750
Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new research led by investigators ...
Oct 13, 2026
0
92
Treating individual metastatic tumors with highly focused radiation or surgery did not improve progression-free or overall survival for patients with oligometastatic breast cancer receiving first-line systemic therapy, according ...
Oct 8, 2026
0
6
A team of hearing specialists at Vanderbilt Health analyzed thousands of data samples in the institution's BioVU biobank to understand genetic susceptibility of sensorineural hearing loss, which is caused by damage to the ...
Oct 8, 2026
0
6
Patients with estrogen receptor-positive (ER+), HER-2-negative advanced breast cancer experienced significantly improved progression-free survival (PFS) when treated with an oral combination regimen that included giredestrant, ...
Oct 1, 2026
0
10
Colon and rectal cancer often spread to the liver. In some patients, the metastases can be surgically removed or destroyed using local treatment with the aim of curing the disease. Despite this, the cancer often returns. ...
Sep 29, 2026
0
9
Atypical meningiomas are tumors that originate in the meninges and are associated with a high risk of recurrence. Until now, it was unclear whether patients benefit from radiotherapy after complete surgical removal of the ...
Sep 25, 2026
0
8
A study by the Faculty of Sport and Health Sciences at the University of Jyväskylä, Finland, found that a high adolescent body mass index (BMI) may be linked to accelerated biological aging in adulthood. The findings, published ...
Sep 21, 2026
0
25
A healthy diet lowers the risk of type 2 diabetes. However, the extent of this protective effect may be influenced by epigenetic factors. This is suggested by a new study conducted by researchers from the German Center for ...
Sep 16, 2026
0
9
Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to chemotherapy, provides durable clinical benefit ...
Sep 15, 2026
0
7
Adding zipalertinib to platinum-pemetrexed chemotherapy significantly improved progression-free survival in patients receiving first-line treatment for advanced non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion ...
Sep 13, 2026
0
7
